著者

天野 雄一郎 宮田 順之 鈴木 琢光 吉村 幸浩 立川 夏夫

出版者

一般社団法人 日本感染症学会

雑誌

感染症学雑誌 (ISSN:03875911)

巻号頁・発行日

vol.92, no.5, pp.690-695, 2018-09-20 (Released:2019-12-01)

参考文献数

20

---

We report herein on a 61-year-old Japanese man with severe falciparum malaria after visiting African countries. He presented with shock, impaired consciousness, acidosis, renal impairment, jaundice, pulmonary edema and hyperparasitemia (42.7%). We admitted him to our intensive-care unit. He was initially treated with intravenous quinine (4,500mg for 3 days), rectal artesunate (1,200mg for 5days) and aggressive supportive therapy. The sequential treatment was mefloquine on day 7 (1,925mg). The 99% parasite clearance time and ICU stay were 92 hours and 8days, respectively. He was discharged without complications on the 28th day. Severe malaria, especially cerebral malaria, is a highly mortal disease requiring urgent treatment. Intravenous artesunate is now recommended as the treatment of choice for severe malaria by the World Health Organization, but it is unavilable in Japan. We found that our combination treatment had excellent antimalarial activity with rapid efficacy, and was safe and well-tolerated.